News

New research reveals prostate cancer survivors face a significant long-term risk of developing a third primary cancer, with a ...
Spatial transcriptomics may transform prostate cancer research by mapping immune cell localization and gene expression in ...
Astellas and Pfizer's Xtandi plus ADT showed a decrease in mortality risk in a metastatic hormone-sensitive prostate cancer ...
Discover a study that also highlighted that treatment intensification with enzalutamide benefited patients regardless of ...
In the largest clinical genomic profiling study of non-Hispanic Black men with metastatic prostate cancer to date, researchers from Moffitt Cancer Center, University of Pennsylvania, University of ...
We’ll dive into breaking news about President Biden’s prostate cancer diagnosis and share firsthand insights from Kyle T. Mosley (a survivor), and the reports from our own HBCU community.
Former United States president Joe Biden has been forced to clarify his cancer timeline following the Donald Trump cover-up ...
Ed Burgess, diagnosed with stage IV prostate cancer, shares his journey of survival thanks to a combination of hormone therapy and the drug enzalutamide, highlighting the personal impact of research ...